Arcturus Therapeutics Holdings (ARCT) Short-term Investments (2023 - 2025)

Arcturus Therapeutics Holdings' Short-term Investments history runs 3 years deep, the most recent figure standing at $55.0 million for Q3 2025.

• Quarterly Short-term Investments changed 0.0% year-over-year to $55.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $55.0 million (changed 0.0% YoY) and the FY2024 annual result came in at $55.0 million, changed 0.0% from the prior year.
• Short-term Investments was $55.0 million for Q3 2025 at Arcturus Therapeutics Holdings, roughly flat from $55.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $55.0 million in Q4 2023 and bottomed at $38.5 million in Q1 2025.
• A 3-year average of $52.9 million and a median of $55.0 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments changed 0.0% — and 2025, when it slumped 30.0%.
• Arcturus Therapeutics Holdings' Short-term Investments stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• Business Quant data shows ARCT's Short-term Investments at $55.0 million in Q3 2025, $55.0 million in Q2 2025, and $38.5 million in Q1 2025.